检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:蔺雅娟 杨晓蕾[1] 夏云龙[1] LIN Yajuan;YANG Xiaolei;XIA Yunlong(Department of Cardiology,The First Affiliated Hospital of Dalian Medical University,Dalian 116011,Liaoning,China)
机构地区:[1]大连医科大学附属第一医院心内科,辽宁大连116011
出 处:《心血管病学进展》2020年第9期911-913,921,共4页Advances in Cardiovascular Diseases
基 金:国家自然科学基金(81900439/81970286)。
摘 要:尿酸是人体中嘌呤经黄嘌呤氧化酶催化代谢的终产物。尿酸也被称为强效抗氧化剂,生理水平的尿酸能阻止H2O2诱导的超氧化物歧化酶的失活,从而维持超氧化物歧化酶活性,起到抗氧化的作用。然而最近多项研究表明,体内高尿酸血症与低尿酸血症均与多种心血管疾病的发生有关。现对体内不同程度尿酸水平与心血管疾病的发生做一综述。Uric acid is the final product of purine catalyzed metabolism in human body by xanthine oxidase.Uric acid is also known as a potent antioxidant.Physiological levels of uric acid can prevent the inactivation of H2 O2-induced superoxide dismutase,thus maintaining superoxide dismutase activity and playing an antioxidant role.However,a number of recent studies have shown that hyperuricemia and hypouricemia in vivo are associated with the occurrence of a variety of cardiovascular diseases.The purpose of this article is to review the occurrence of different levels of uric acid in vivo and cardiovascular diseases.
分 类 号:R54[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28